Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | NPC1 | O15118 | 4/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | GRM4 | Q14833 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3629451 | 1.00 | MEN1 (0.57) | MEN1KMT2ANPC1RAB9AATM | |
| Hydrochloric Acid SCHEMBL5470036 | 0.98 | NPC1 (0.55) | MEN1KMT2ANPC1RAB9AATM | |
| Hydrochloric Acid SCHEMBL591897 | 0.98 | NPC1 (0.55) | MEN1KMT2ANPC1RAB9AATM | |
| Hydrochloric Acid SCHEMBL29443430 | 0.98 | NPC1 (0.55) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL28595722 | 0.84 | KMT2A (0.80) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL29419010 | 0.84 | KMT2A (0.80) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL14385683 | 0.82 | NPC1 (0.57) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL16070584 | 0.79 | MEN1 (0.64) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL4638429 | 0.79 | MEN1 (0.64) | MEN1KMT2ANPC1RAB9AATM | |
| SCHEMBL31611950 | 0.79 | MEN1 (0.64) | MEN1KMT2ANPC1RAB9AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2604702-B1 | Methods for direct detection of DNA damage | UNIV CHICAGO (US) | 2015-07-01 | — | — | EP | claimed |
| US-20140220696-A1 | METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA DAMAGE | UNIVERSITY OF CHICAGO (US) | 2014-08-07 | — | — | US | claimed |
| US-8580516-B2 | Methods and compositions for direct detection of DNA damage | UNIVERSITY OF CHICAGO (US) | 2013-11-12 | — | — | US | claimed |
| EP-2604702-A1 | Methods and compositions for direct detection of DNA damage | The University of Chicago (US) | 2013-06-19 | — | — | EP | claimed |
| US-20100216132-A1 | METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA DAMAGE | UNIVERSITY OF CHICAGO | 2010-08-26 | — | — | US | claimed |
| WO-2002094769-A1 | SOLID REAGENT FOR SAMPLING AND DERIVATIZATION OF CARBONYL COMPOUNDS | SEQUANT AB (SE) | 2002-11-28 | — | — | WO | claimed |
| EP-0553054-A2 | A process for the examination of individual items for the contents of a fat-soluble compound | Slagteriernes Forskningsinstitut (DK) | 1993-07-28 | — | — | EP | claimed |
| EP-2604702-B1 | Methods for direct detection of DNA damage | UNIV CHICAGO (US) | 2015-07-01 | — | — | EP | disclosed |
| US-20140220696-A1 | METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA DAMAGE | UNIVERSITY OF CHICAGO (US) | 2014-08-07 | — | — | US | disclosed |
| US-8580516-B2 | Methods and compositions for direct detection of DNA damage | UNIVERSITY OF CHICAGO (US) | 2013-11-12 | — | — | US | disclosed |
| EP-2604702-A1 | Methods and compositions for direct detection of DNA damage | The University of Chicago (US) | 2013-06-19 | — | — | EP | disclosed |
| EP-2334814-A1 | METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA DAMAGE | Solulink Biosciences, Inc. (US) | 2011-06-22 | — | — | EP | disclosed |
| US-20100216132-A1 | METHODS AND COMPOSITIONS FOR DIRECT DETECTION OF DNA DAMAGE | UNIVERSITY OF CHICAGO | 2010-08-26 | — | — | US | disclosed |
| US-20060040879-A1 | Chloroquine coupled nucleic acids and methods for their synthesis | KOSAK KENNETH M | 2006-02-23 | — | — | US | disclosed |
| US-20050153913-A1 | Nucleic acid carrier compositions and methods for their synthesis | KOSAK KENNETH M (US) | 2005-07-14 | — | — | US | disclosed |
| WO-2002094769-A1 | SOLID REAGENT FOR SAMPLING AND DERIVATIZATION OF CARBONYL COMPOUNDS | SEQUANT AB (SE) | 2002-11-28 | — | — | WO | disclosed |
| EP-0449295-B1 | Novel quinoxalinone derivative | BIO SENSOR KENKYUSHO KK (JP) | 1996-06-26 | — | — | EP | disclosed |
| US-5324835-A | Useful as luminescent labelling reagents or reagents for determining hydrogen peroxide | BIOSENSOR LABORATORIES CO., LTD. (JP) | 1994-06-28 | — | — | US | disclosed |
| EP-0553054-A2 | A process for the examination of individual items for the contents of a fat-soluble compound | Slagteriernes Forskningsinstitut (DK) | 1993-07-28 | — | — | EP | disclosed |
| EP-0449295-A1 | Novel quinoxalinone derivative | BIOSENSOR LABORATORIES CO., LTD. (JP) | 1991-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060040879-A1 | Chloroquine coupled nucleic acids and methods for their synthesis | TLR9, TLR3, EXOSC5 | MEN1 3610/4885KMT2A 2007/4885NPC1 246/4885 |
| US-20050153913-A1 | Nucleic acid carrier compositions and methods for their synthesis | DNA2, POLRMT, SLC29A2 | MEN1 2855/4885KMT2A 4153/4885NPC1 581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.